Meningococcal polyvalent vaccine is routinely recommended to:: (A) Adolescents young males, (B) All healthy children between 5-7 years of age, (C) More than 50 years of age diabetic patients on regular insulin, (D) 40 years old paramedical staff working in laboratory
Answer is B. Ans. b. All healthy children between 5-7 years of age (Ref: Park 23/e p166, 22/e p157)'Quadrivalent (polyvalent) vaccines are administered as a single dose to individuals aged >_ 2 years.'- Park 22/e p157Meningococcal VaccinesPolysaccharide VaccinesConjugate Vaccines* Available against Meningococci of serogroup A, C, W135, and Y.* Types:- Bivalent (A, C)- Trivalent (A, C, W135)- Quadrivalent (A, C, W135, Y)* Polysaccharide vaccines are administered as a single dose to persons > 2 years old* Most of these vaccines are given subcutaneously* MC reaction is 1-2 days of pain and redness at the site of injection in 4-56% of recipients* More immunogenic, induce immunogenic memory* Types:- Monovalent (A or C)- Quadrivalent (A, C, W135, Y)* Given as IM injection, preferably in deltoid muscle (or in the anterolateral aspect of thigh in children <12 months)* Monovalent Men A conjugate vaccine should be given as a single dose to individuals 1-29 years of age* For Monovalent Men C conjugate vaccine, one single IM dose is recommended for children aged > 12 months, teenagers and adults. Children 2-11 months of age require 2 doses administration at an interval of at least 2 months and a booster about 1 year thereafter.* Quadrivalent vaccines are administered as a single dose to individuals aged > 2 years.